Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study

被引:1276
|
作者
Knochenhauer, ES
Key, TJ
Kahsar-Miller, M
Waggoner, W
Boots, LR
Azziz, R
机构
[1] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Occupat Hlth, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA
来源
关键词
D O I
10.1210/jc.83.9.3078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimates of the prevalence of the polycystic ovary syndrome (PCOS) in the general population have ranged from 2-20%. The vast majority of these reports have studied White populations in Europe, used limited definitions of the disorder, and/or used bias populations, such as those seeking medical care. To estimate the prevalence of this disorder in the United States and address these limitations, we prospectively determined the prevalence of PCOS in a reproductive-aged population of 369 consecutive women (174 White and 195 Black; aged 18-45 yr), examined at the time of their preemployment physical. Body measures were obtained, and body hair was quantified by a modified Ferriman-Gallwey (F-G) method. All exams were initially performed by 2 trained nurses, and any subject with an F-G score above 3 was reexamined by a physician, the same for all patients. Of the 369 women, 277 (75.1%) also agreed to complete a questionnaire and have additional blood drawn. Subjects were studied regardless of current estrogen/progestin hormonal use (28.5%). PCOS was defined as 1) oligoovulation, 2) clinical hyperandrogenism (i.e. hirsutism) and/or hyperandrogenemia, and 3) exclusion of other related disorders, such as hyperprolactinemia, thyroid abnormalities, and nonclassic adrenal hyperplasia. Hirsutism was defined by a F-G score of 6 or more, and hyperandrogenemia was defined as a total or free testosterone, androstenedione, and/or dehydroepiandrosterone sulfate level above the 95th percentile of control values [i,e, all eumenorrheic women in the study, who had no hirsutism (F-G less than or equal to 5) or acne and were receiving no hormonal therapy; n = 98]. Considering all 369 women studied, White and Black women had similar mean ages (29.4 +/- 7.1 and 31.1 +/- 7.8 yr, respectively), although White women had a lesser body mass than Black women (24.9 +/- 6.1 vs. 29.2 +/- 8.1 kg/m(2), respectively; P < 0.001). Of these 7.6%, 4.6%, and 1.98 demonstrated a F-G score of 6 or more, 8 or 10, respectively, and there was no significant racial difference, with hirsutism prevalences of 8.0%, 2.8%, and 1.6% in Whites, and 7.1%, 6.1%, and 2.1% in Blacks, respectively. Of the 277 women consenting to a history and hormonal evaluation, 4.0% had PCOS as defined, 4.7% (6 of 129) of Whites and 3.4% (5 of 148) of Blacks. In conclusion, in our consecutive population of unselected women the prevalence of hirsutism varied from 2-8% depending on the chosen cut-off F-G score, with no significant difference between White and Black women. Using an F-G score of 6 or more as indicative of hirsutism, 3.4% of Blacks and 4.7% of Whites had PCOS as defined. These data suggest that PCOS may be one of most common reproductive endocrinological disorders of women.
引用
收藏
页码:3078 / 3082
页数:5
相关论文
共 50 条
  • [41] Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome
    Mafaldo Soares, Elvira Maria
    Azevedo, George Dantas
    Nobrega Gadelha, Rafael Goncalves
    Araujo Moura Lemos, Telma Maria
    Oliveira Maranhao, Tecia Maria
    FERTILITY AND STERILITY, 2008, 89 (03) : 649 - 655
  • [42] Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019
    Yu, Onchee
    Christ, Jacob P.
    Schulze-Rath, Renate
    Covey, Jennifer
    Kelley, Ann
    Grafton, Jane
    Cronkite, David
    Holden, Erika
    Hilpert, Jan
    Sacher, Frank
    Micks, Elizabeth
    Reed, Susan D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 229 (01) : 39.e1 - 39.e12
  • [43] Management of polycystic ovary syndrome in postmenopausal women: a medical black hole
    Fenton, Anna
    Panay, Nick
    CLIMACTERIC, 2008, 11 (02) : 89 - 90
  • [44] Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia
    Boyle, Jacqueline A.
    Cunningham, Joan
    O'Dea, Kerin
    Dunbar, Terry
    Norman, Robert J.
    MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (01) : 62 - 66
  • [45] Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome
    Luo, Xi
    Cai, Wang-Yu
    Wu, Xiao-Ke
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [46] Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome
    Christian, RC
    Dumesic, DA
    Behrenbeck, T
    Oberg, AL
    Sheedy, PF
    Fitzpatrick, LA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06): : 2562 - 2568
  • [47] Association of Gut Microbiota With Fatigue in Black Women With Polycystic Ovary Syndrome
    Slack, Julia E.
    Kosyakova, Natalia
    Pelkmans, Jordan L.
    Houser, Madelyn C.
    Dunbar, Sandra B.
    Spencer, Jessica B.
    Ferranti, Erin P.
    Narapareddy, S. Laren
    NURSING RESEARCH, 2025, 74 (01) : 56 - 63
  • [48] Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
    Ganie, Mohd Ashraf
    Chowdhury, Subhankar
    Malhotra, Neena
    Sahay, Rakesh
    Bhattacharya, Prasanta Kumar
    Agrawal, Sarita
    Jabbar, P. K.
    Suri, Vanita
    Rozati, Roya
    Sreenivas, Vishnubhatla
    Baba, Mohammad Salem
    Wani, Imtiyaz Ahmad
    Rashid, Haroon
    Nair, Abhilash
    Shukla, Amlin
    Arora, Taruna
    Kulkarni, Bharati
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [49] Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
    Ehrmann, DA
    Barnes, RB
    Rosenfield, RL
    Cavaghan, MK
    Imperial, J
    DIABETES CARE, 1999, 22 (01) : 141 - 146
  • [50] THE PREVALENCE OF DEPRESSION AND POOR QUALITY OF LIFE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Miulescu, R. Danciulescu
    Danoiu, S.
    Danoiu, M.
    Poiana, C.
    Cristescu, V.
    EUROPEAN PSYCHIATRY, 2010, 25